| 000 | 01801 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516085108.0 | ||
| 264 | 0 | _c20121204 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1618-095X | ||
| 024 | 7 |
_a10.1016/j.phymed.2012.03.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYe, Ming-Xiang | |
| 245 | 0 | 0 |
_aCurcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms. _h[electronic resource] |
| 260 |
_bPhytomedicine : international journal of phytotherapy and phytopharmacology _cJun 2012 |
||
| 300 |
_a779-87 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xmetabolism |
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdenocarcinoma of Lung |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCisplatin _xpharmacology |
| 650 | 0 | 4 |
_aCurcumin _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxia-Inducible Factor 1, alpha Subunit _xmetabolism |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 700 | 1 | _aZhao, Yi-Lin | |
| 700 | 1 | _aLi, Yan | |
| 700 | 1 | _aMiao, Qing | |
| 700 | 1 | _aLi, Zhi-Kui | |
| 700 | 1 | _aRen, Xin-Ling | |
| 700 | 1 | _aSong, Li-Qiang | |
| 700 | 1 | _aYin, Hong | |
| 700 | 1 | _aZhang, Jian | |
| 773 | 0 |
_tPhytomedicine : international journal of phytotherapy and phytopharmacology _gvol. 19 _gno. 8-9 _gp. 779-87 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.phymed.2012.03.005 _zAvailable from publisher's website |
| 999 |
_c21685573 _d21685573 |
||